INmune Bio (INMB) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

INMB is expected to report earnings to rise 4.80% to -52 cents per share on October 30

Q3'24

Est.

$-0.52

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.08

Q4'23

Missed

by $0.04

Q3'23

Missed

by $0.08

The last earnings report on August 01 showed earnings per share of -50 cents, beating the estimate of -62 cents. With 119.67K shares outstanding, the current market capitalization sits at 103.52M.

View a ticker or compare two or three

Compare

INMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INMB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for INMB (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 NE Mizner Boulevard

Phone

+1 858 964-3720

Employees

Web

https://www.inmunebio.com